About
Technology
Issues
FAQ
Links
Official Page
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.